Table 1.
(A) | ||||||||
Author and year | Citation | Duration of programme | Population screened | Screened (n) | Screening protocol | Screening test used | Screening personnel | Diagnostic test |
Biswas et al 2012 | 104 | 2 years | Newborns | 490 | 1 stage | DPOAE | Not mentioned | Not mentioned |
Paul 2011 | 81 | 7 years | Newborns | 10 165 | 2 stage | OAE+OAE (non-mentioned DP/TE) | Person with basic knowledge in computer with training on NHS | Diagnostic ABR |
Mishra et al 2013 | 32 | 3 years | 0–2 years | 1101 | <6 months of age, 5 stage; 6 months–1 year, 4 stage; 1–2 years, 3 stage | DPOAE | Not mentioned | Diagnostic ABR |
Ramesh et al 2012 | 85 | 2 years | Newborns | 425 | 1 stage | Calibrated noise maker-based Behavioral Observation Audiometry (BOA) | Trained health workers (30 hours of training) | Diagnostic ABR, OAE and BOA |
Rai et al 2013 | 63 | 1 year | Newborns | 500 | 3 stage | TEOAE+TEOAE+TEOAE | ENT Specialist (Ear Nose Throat) | Diagnostic ABR |
Kumar et al 2015 | 17 | 1 year 8 months | High risk <2 years of age | 500 | 2 stage | TEOAE+AABR | Audiologist | Not mentioned |
Gupta et al 2015 | 50 | 1 year | Newborns | 2265 | 2 stage | AABR+AABR | Single specialist staff | Not mentioned |
Vignesh et al 2015 | 18 | 1.5 years | Newborns | 1405 | 2 stage | TEOAE+AABR | Not mentioned | Diagnostic ABR |
Vishwakarma et al 2015 | 54 | 1 year 8 months | Newborns | Well babies: 2000 High risk:1020 |
3 stage | TEOAE+TEOAE+AABR | Nurse, resident doctor/certified audiologist | Diagnostic ABR |
Paul et al 2016 | 33 | 11 years | Newborns | Well babies: 84 774 High risk: 16 914 |
2 stage | OAE+OAE (non-mentioned DP/TE) | Person with basic training in hearing screening | Diagnostic ABR |
Sharma et al 2018 | 86 | 3 years | Newborns | 2534 | 2 stage | DPOAE | Not mentioned | Diagnostic ABR |
Kumar et al 2016 | 105 | 2 years | Newborns | 1537 | 2 stage | TEOAE+TEOAE+AABR | Not mentioned | Not mentioned |
Sachdeva et al 2017 | 87 | 10 months | Newborns | 2254 | 2 stage | (HRR+BOA+DPOAE)+DPOAE | Not mentioned | Confirmatory, diagnostic ABR |
Kumar et al 2017 | 82 | No info | Newborns | 600 | 2 stage | TEOAE+DPOAE | Not mentioned | Not mentioned |
Swain et al 2017 | 88 | 1.5 years | Newborns | 410 | 2 stage | DPOAE+DPOAE | Not mentioned | Diagnostic ABR |
Bhat et al 2018 | 19 | 1 year | High-risk newborns | 195 | 1 stage | TEOAE | Not mentioned | Diagnostic ABR |
Bishnoi et al 2018 | 89 | No info | Newborns | 2000 | 2 stage | (OAE and Tymp)+OAE (non-mentioned DP/TE) | Not mentioned | Diagnostic ABR |
Parab et al 2018 | 34 | 3 years | Newborns | 8192 | 2 stage | TEOAE+TEOAE | Audiologist | Diagnostic ABR |
Jacob et al 2020 | 35 | 2 years | Newborns | 773 | 2 stage | TEOAE+TEOAE | Not mentioned | Diagnostic ABR |
Nishad et al 2020 | 36 | 1 year | Newborns | 1000 | 2 stage | OAE+OAE (non-mentioned DP/TE) | Not mentioned | Diagnostic ABR |
Sija et al 2022 | 37 | 4 years | Newborns | 16 265 | 2 stage | DPOAE+DPOAE | Trained nurse | Diagnostic ABR |
(B) | ||||||||
Author and year | Citation | Duration of programme | Population screened | Screened (n) | Screening protocol | Screening test used | Screening personnel | Diagnostic test |
Zhang et al 2012 | 106 | 1.5 years | Newborns | 10 043 | 2 stage+genetic screening | TEOAE+(TEOAE and AABR) | Nurse | Not mentioned |
Tobe et al 2013 | 83 | 2 years | Newborns | Not mentioned | 2 stage | OAE+AABR (non-mentioned DP/TE) | Trained personnel, no info | Not mentioned |
Chen et al 2012 | 38 | 2 years | Newborns | 11 568 | 2 stage | TEOAE | Audiologist | Diagnostic ABR, TFT, impedance, ASSR at hospital |
Shang et al 2016 | 52 | 6 months | Newborns | 1064 | 2 stage | First protocol: TEOAE+TEOAE Second protocol: (TEOAE and ABR screen)+TEOAE |
Not mentioned | Diagnostic ABR |
Wenjin et al 2018 | 20 | 2 years | Newborns | 19 098 | 2 stage | Well babies: DPOAE+ABR screening High-risk babies: (DPOAE and ABR screening) (DPOAE and ABR screening) |
Nurse | Otoscopy, diagnostic ABR at 30 dBHL, Tymp; DPOAEs |
Wang et al 2019 | 21 | 5 years | Newborns | 55 977 | 2 stage | OAE+AABR (non-mentioned DP/TE) | Nurse | Comprehensive diagnostic audiometry around 3 months of age |
Dai et al 2019 | 22 | 1 year | Newborns | 180 469 | 2 stage+genetic screening | TEOAE+(TEOAE and AABR) | Not mentioned | Diagnostic ABR, ASSR, DPOAE, immitance |
Zeng et al 2020 | 23 | 1 year | Newborns | 4205 | 2 stage+genetic screening | OAE+AABR screening (non-mentioned DP/TE) | Not mentioned | No |
Wen et al 2020 | 24 | 2 years | Newborns | 467 980 | 2 stage | OAE+(OAE and AABR) (non-mentioned DP/TE) | Not mentioned | Not mentioned |
Guo et al 2020 | 25 | 2 years 4 months | Infants >3 months | 287 430 | 2 stage+genetic | OAE+AABR (non-mentioned DP/TE) | Not mentioned | Diagnostic ABR |
Guomei et al 2022 | 53 | 9 months | Newborns | 2174 | 2 stage+genetic | OAE+OAE (non-mentioned DP/TE) | Not mentioned | Diagnostic ABR |
(C) | |||||||||
Author and year | Citation | Country | Duration of programme | Population screened | Screened (n) | Screening protocol | Screening test used | Screening personnel | Diagnostic test |
Ahmad et al 2011 | 64 | Malaysia (MIC) | 5 years | Newborns | 16 000 | 3 stage | DPOAE+DPOAE+DPOAE | Technician, staff nurse, ward attendants | Diagnostic ABR |
Wong et al 2021 | 26 | Malaysia (UMIC) | 2 years | Newborns | 28 432 | 1 and 2 stage | 1 stage: AABR 2 stage: DPOAE+AABR |
Nurses | Diagnostic ABR |
Tungvachirakul et al 2011 | 39 | Thailand (UMIC) | 1 year 11 months | Newborns | 4043 | 2 stage | OAE+OAE (not mentioned DP/TE) | Not mentioned | ASSR |
Poonual et al 2016 | 107 | Thailand (UMIC) | 1 year 7 months | Newborns | 3120 | 2 stage | Automated TEOAE+conventional TEOAE | Not mentioned | Diagnostic ABR |
Poonual et al 2017 | 27 | Thailand (UMIC) | Not mentioned | Newborns | 3120 | 3 stage | COBRA HRR tool+TEOAE+AABR | Not mentioned | Not mentioned |
Poonual et al 2017 | 96 | Thailand (UMIC) | 1 year | Newborns | 3120 | 2 stage | TEOAE+AABR | Not mentioned | ABR at 3 and 8 months |
Pitathawatchai et al 2019 | 40 | Thailand (UMIC) | 1 year 7 months | Newborns | 6140 | 2 stage | TEOAE+TEOAE | Nurses | Not mentioned |
Ray et al 2021 | 41 | Nepal (LMIC) | 2 years | Newborns | 540 | 2 stage | OAE+OAE (not mentioned DP/TE) | Not mentioned | Diagnostic OAE and diagnostic ABR |
Mazlan et al 2022 | 28 | Malaysia (UMIC) | 10 years | Newborns | 50 633 | 2 stage | TEOAE+AABR | Trained nurses and medical technologists | Diagnostic ABR |
Shameem et al 2022 | 42 | Bangladesh (LMIC) | 2 years | High-risk newborns | 426 | 2 stage | TEOAE+TEOAE | Not mentioned | Diagnostic ABR |
Khaimook et al 2022 | 43 | Thailand (UMIC) | 6 months | Newborns | 1696 | 2 stage | TEOAE+TEOAE | Trained nurse and audiologist | Diagnostic ABR+Tymp |
(D) | ||||||||
Author and year | Citation | Duration of programme | Population screened | Screened (n) | Screening protocol | Screening test used | Screening personnel | Diagnostic test |
Tasci et al 2010 | 55 | 14 months | Newborns | 16 975 | 3 steps | TEOAE+TEOAE+ ABR | Audiology technician | Diagnostic ABR |
Sennaroglu et al 2011 | 44 | 1 year | Newborns | 1840 | 2 stage | TEOAE | Audiologist or audiometrist | Diagnostic ABR; |
Ulusoy et al 2014 | 56 | 3 years | Newborns | 11 575 | 3 stage | TEOAE+AABR | 2 audiometrists and 1 nurse | Diagnostic ABR, the level 3 centre |
Kemaloğlu et al 2016 | 57 | 10 years | Newborns | 19 436 (I/P) 2083 (O/P) |
3 stage | TEOAE+TEOAE+(TEOAE and AABR) | Audiology technicians and audiology students | Diagnostic ABR |
Yorulmaz et al 2017 | 58 | 5 years | Newborns | 13 693 | 3 stage | TEOAE+TEOAE+AABR | Audiometrist | Diagnostic ABR, Tymp, acoustic reflexes, ASSR |
Çelik et al 2016 | 45 | 6 years | Newborns | 142 128 | 2 stage | TEOAE (twice same day)+TEOAE | Not mentioned | Diagnostic ABR |
Ozturk et al 2017 | 59 | 2 years | Newborns | 7502 | 3 stage | Wellbabies: DPOAE+DPOAE+ ABR screening Highrisk babies: Direct ABR |
Audiologist | Diagnostic ABR |
Hamdi 2018 | 60 | 2 years | Newborns | 1808 | 3 stage | TEOAE+TEOAE+ABR screening | Nurses (trained) | Diagnostic ABR |
Yücel et al 2019 | 65 | 2 years | Newborns | 786 Syrian and 7230 turkish | 3 stage | (TEOAE and Tymp)+TEOAE+ABR | Not mentioned | Detailed testing |
Arslan et al 2013 | 46 | 8 months | Newborns | 2229 | 2 stage | TEOAE+TEOAE | Nurse | Diagnostic ABR |
Çıkrıkçı et al 2020 | 51 | 1.5 years | Newborns | 702 turkish 172 syrian |
2 stage | AABR+AABR | Not mentioned | Diagnostic ABR |
(E) | ||||||||
Author and year | Citation | Duration of programme | Population screened | Screened (n) | Screening protocol | Screening test used | Screening personnel | Diagnostic test |
Arjmandi et al 2012 | 47 | 1 year | Newborns | 1232 | 2 stage | TEOAE+TEOAE | Not mentioned | Diagnostic ABR |
Islami et al 2013 | 48 | 1.5 years | Newborns | 7250 | 2 stage | TEOAE+TEOAE | Audiologists | Diagnostic ABR |
Firoozbakht et al 2014 | 29 | 8 years | Newborns | 3 350 995 | 2 stage | TEOAE+AABR | Audiologists, nurses, midwives and trained health technicians. | Comprehensive test |
Zahed et al 2014 | 30 | 8 years | Newborns | 40 930 | 2 stage | TEOAE+ABR | Audiologists | ABR/ASSR and immittance audiometry, |
Farhat et al 2014 | 90 | 2 years | Newborns | 8987 | 2 stage | TEOAE+TEOAE | Not mentioned | ASSR |
Haghshenas et al 2014 | 61 | 2 years | Newborns | 15 165 | 3 stage | OAE+OAE+(OAE and AABR) (not mentioned DP/TE) | Audiologist | ABR screening |
Baradaranfar et al 2014 | 108 | 1 year | Newborns | 514 | 2 stage | TEOAE+TEOAE | Not mentioned | Diagnostic ABR |
Azizi et al 2016 | 49 | 1.5 years | Newborns | 3818 | 2 stage | TEOAE+TEOAE | not mentioned | ABR, |
Tajik et al 2016 | 31 | 4 years | Newborns | 3362 | 2 stage | TEOAE+(TEOAE and ABR) | Not mentioned | Not mentioned |
Saki et al 2017 | 84 | 3 years | Newborns | 92 521 | 2 stage | First and second:TEOAE+AABR | Audiologists | Diagnostic OAE and ABR |
Rahimi et al 2018 | 62 | 5 years | Newborns | 4729 | 3 stage | TEOAE+TEOAE+AABR | Audiologist | Diagnostic ABR |
AABR, automated auditory brainstem response; ABR, auditory brainstem response; ASSR, auditory steady-state response; BOA, behavioral observation audiometry; DPOAE, distortion product otoacoustic emission; LMIC, lower middle-income country; MIC, middle-income country; NHS, newborn hearing screening; OAE, otoacoustic emission; PTA, pure tone audiometry; TEOAE, transient evoked otoacoustic emission; Tymp, tympanometry; UMIC, upper middle-income country.